{"nct_id":"NCT02180061","title":"Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041)","status":"COMPLETED","status_verified_date":"2020-03","start_date":"2014-07-15","start_date_type":"ACTUAL","primary_completion_date":"2017-08-31","primary_completion_date_type":"ACTUAL","completion_date":"2017-08-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}